Literature DB >> 31678930

Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion.

Antoine Méant1, Beichen Gao1, Geneviève Lavoie1, Sami Nourreddine1, Flora Jung1, Léo Aubert1, Joseph Tcherkezian1, Anne-Claude Gingras2,3, Philippe P Roux4,5.   

Abstract

The RAS/mitogen-activated protein kinase (MAPK) signaling pathway regulates various biological functions, including cell survival, proliferation and migration. This pathway is frequently deregulated in cancer, including melanoma, which is the most aggressive form of skin cancer. RSK (p90 ribosomal S6 kinase) is a MAPK-activated protein kinase required for melanoma growth and proliferation, but relatively little is known about its function and the nature of its cellular partners. In this study, we used a proximity-based labeling approach to identify RSK proximity partners in cells. We identified many potential RSK-interacting proteins, including p120ctn (p120-catenin), which is an essential component of adherens junction (AJ). We found that RSK phosphorylates p120ctn on Ser320, which appears to be constitutively phosphorylated in melanoma cells. We also found that RSK inhibition increases melanoma cell-cell adhesion, suggesting that constitutive RAS/MAPK signaling negatively regulates AJ integrity. Together, our results indicate that RSK plays an important role in the regulation of melanoma cell-cell adhesion.
© 2020 Méant et al.

Entities:  

Keywords:  BRAF; Cell-cell interactions; MAPK; RSK; adherens junction; melanoma; p120ctn; phosphorylation; protein kinases; protein-protein interactions

Mesh:

Substances:

Year:  2019        PMID: 31678930      PMCID: PMC6944238          DOI: 10.1074/mcp.RA119.001811

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  62 in total

Review 1.  Cadherins in development: cell adhesion, sorting, and tissue morphogenesis.

Authors:  Jennifer M Halbleib; W James Nelson
Journal:  Genes Dev       Date:  2006-12-01       Impact factor: 11.361

2.  RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.

Authors:  P A Bignone; K Y Lee; Y Liu; G Emilion; J Finch; A E R Soosay; F M L Charnock; S Beck; I Dunham; A J Mungall; T S Ganesan
Journal:  Oncogene       Date:  2006-07-31       Impact factor: 9.867

Review 3.  Regulation of RAF protein kinases in ERK signalling.

Authors:  Hugo Lavoie; Marc Therrien
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05       Impact factor: 94.444

Review 4.  A New View of Ras Isoforms in Cancers.

Authors:  Ruth Nussinov; Chung-Jung Tsai; Mayukh Chakrabarti; Hyunbum Jang
Journal:  Cancer Res       Date:  2015-12-10       Impact factor: 12.701

5.  E- and N-cadherin differ with respect to their associated p120ctn isoforms and their ability to suppress invasive growth in pancreatic cancer cells.

Authors:  Bjoern Seidel; Simone Braeg; Guido Adler; Doris Wedlich; Andre Menke
Journal:  Oncogene       Date:  2004-07-15       Impact factor: 9.867

Review 6.  The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition.

Authors:  S Meloche; J Pouysségur
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

7.  RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells.

Authors:  Ulrik Doehn; Camilla Hauge; Scott R Frank; Claus J Jensen; Katarzyna Duda; Jakob V Nielsen; Michael S Cohen; Jens V Johansen; Benny R Winther; Leif R Lund; Ole Winther; Jack Taunton; Steen H Hansen; Morten Frödin
Journal:  Mol Cell       Date:  2009-08-28       Impact factor: 17.970

Review 8.  BRAF(E600) in benign and malignant human tumours.

Authors:  C Michaloglou; L C W Vredeveld; W J Mooi; D S Peeper
Journal:  Oncogene       Date:  2007-08-27       Impact factor: 9.867

Review 9.  p120catenin alteration in cancer and its role in tumour invasion.

Authors:  Florent Peglion; Sandrine Etienne-Manneville
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-09-23       Impact factor: 6.237

Review 10.  Close encounters of the RNAi kind: the silencing life of the adherens junctions.

Authors:  Antonis Kourtidis; Panos Z Anastasiadis
Journal:  Curr Opin Cell Biol       Date:  2018-03-26       Impact factor: 8.382

View more
  3 in total

1.  mTORC2 Is Involved in the Induction of RSK Phosphorylation by Serum or Nutrient Starvation.

Authors:  Po-Chien Chou; Swati Rajput; Xiaoyun Zhao; Chadni Patel; Danielle Albaciete; Won Jun Oh; Heineken Queen Daguplo; Nikhil Patel; Bing Su; Guy Werlen; Estela Jacinto
Journal:  Cells       Date:  2020-06-27       Impact factor: 6.600

2.  Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer.

Authors:  Derek K Cheng; Tobiloba E Oni; Jennifer S Thalappillil; Youngkyu Park; Hsiu-Chi Ting; Brinda Alagesan; Nadia V Prasad; Kenneth Addison; Keith D Rivera; Darryl J Pappin; Linda Van Aelst; David A Tuveson
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

3.  Mass Spectrometry-Based Discovery of in vitro Kinome Substrates.

Authors:  Naoyuki Sugiyama
Journal:  Mass Spectrom (Tokyo)       Date:  2020-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.